What is Cerebrolysin?
Cerebrolysin is a mixture of low-molecular-weight neuropeptides and free amino acids derived from porcine brain tissue. It has neurotrophic properties similar to naturally occurring nerve growth factors. Approved in many countries for stroke recovery, traumatic brain injury, and dementia.
Key Benefits & Mechanisms
Neurotrophic factor-like activity
Neuroprotection in stroke and TBI
Improved cognitive function in dementia
Promotes neuronal survival and plasticity
Reduces amyloid pathology
Enhanced recovery from brain injuries
Synaptic repair and neurogenesis
Research Summary
Cerebrolysin has extensive clinical evidence with over 200 clinical studies. Approved in more than 45 countries for neurological conditions. Cochrane reviews show moderate evidence for vascular dementia. Large-scale trials (CARS, CASTA) demonstrate benefits in stroke recovery.